The Sanofi-GSK vaccine candidate has just passed the phase 2 trial. "An important step has just been taken", welcomed the president of Sanofi France, Olivier Bogillot, on Monday morning at the microphone. 'Europe 1.
INTERVIEW
The announcement was made on Monday morning: the vaccine candidate from Sanofi-GSK has successfully passed the phase 2 trial. "It is a very important step which has just been taken", reacted the president of Sanofi France, Olivier Bogillot, guest of Sonia Mabrouk on Europe 1 this Monday morning.